Macrophage Enhancement of Tumor Cell Extravasation and Intravasation In Vitro

Alessandro Genna1, Francisco W Puerta Martinez2, John C McAuliffe3,4,5,6,7

  • 1Department of Immunology and Regenerative Biology, Weizmann Institute of Science, Rehovot, Israel.

Insights

This study introduces a 3D in vitro model to investigate how macrophages enhance tumor cell intravasation and extravasation, crucial steps in cancer metastasis. The assay provides high-resolution insights into metastatic dissemination using breast and pancreatic cancer cell lines.

Area of Science:

  • Oncology
  • Cell Biology
  • Cancer Research

Background:

  • Macrophages are key regulators of the tumor microenvironment.
  • They promote tumor cell invasion, intravasation, and extravasation, driving metastatic progression.
  • Understanding these processes requires advanced in vitro models.

Purpose of the Study:

  • To describe a novel in vitro protocol for examining macrophage-enhanced tumor cell extravasation and intravasation.
  • To utilize a 3D stratified co-culture transendothelial migration (TEM) transwell system.
  • To demonstrate the assay's utility with breast and pancreatic tumor cell lines.

Main Methods:

  • Development of a 3D co-culture transwell system.
  • Stratified culture of macrophages and tumor cells.
  • Assessment of tumor cell transendothelial migration (intravasation and extravasation).

Main Results:

  • The developed 3D TEM assay successfully models macrophage-enhanced tumor cell extravasation and intravasation.
  • The protocol allows for high-resolution examination of metastatic dissemination.
  • The assay demonstrated utility with both breast and pancreatic cancer cell lines.

Conclusions:

  • This 3D in vitro TEM system is a valuable tool for studying macrophage roles in cancer metastasis.
  • The assay can be broadly applied to investigate various aspects of metastatic dissemination.
  • It offers a high-resolution platform for preclinical research in oncology.

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.3K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.3K